Adaptive and maladaptive emotions in patients with cancer: identification of indicators (EMOCA study)

Adaptive and maladaptive emotions in patients with cancer: identification of indicators (EMOCA study) - EMOCA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54248

Enrollment

160

Registered

2020-08-24

Start date

2021-08-10

Completion date

Unknown

Last updated

2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adaptiviteit van emoties (mal)adaptive emotions adjustment of emoties

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - diagnosis of a solid malignancy cancer, (i) non-metastatic disease or (ii) metastatic disease; - between 3 and 7 months after start of treatment with (neo)adjuvant or 1st line chemotherapy, or immunotherapy; - life expectancy of more than 3 months.

Exclusion criteria

Exclusion criteria: - age*

Design outcomes

Primary

Measure	Time frame
Emotional symptoms, cancer-treatment-related symptoms and activities, specific signs and symptoms are identified by an oncologist and nurse through a checklist, life goals, diagnostic mental health interview, the need for professional mental health care, psychosocial symptoms and threatening experiences.	—

Secondary

Measure	Time frame
sleep (problems), mastery (the feeling to which a person perceives himself or herself to be in control of events and ongoing situations), emotional reactivity in daily life, instrumental and social support.	—

Countries

Netherlands

Outcome results